Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Infection

• Preventive Therapy of Postoperative Intra-abdominal Infection Based on Serum Lactate Changes
• Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19
• Efficacy of Dalbavancin in Osteoarticular Infections Associated With Hip and Knee Replacements
• Prevention and Treatment of Patient Before, During, and After Covid-19 Infection
• BK With VST for Kidney Transplant Patients
• Programmed Cell Death Protein-1 (PD-1) Monoclonal Antibody for EBV-HLH and CAEBV as First-line Therapy
• Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization
• A Study to Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections
• Complications After Lower Third Molar Surgery
• Azithromycin Plus Hydroxychloroquine for COVID-19 Infection
• Vaginal Cleaning Using Povidone Iodine Before CS to Reduce Postoperative Wound Infection
• Microbiome and Association With Implant Infections
• Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of PA1010 in HBV Patients
• Tetracycline Versus Doxycycline for HP Rescue Therapy
• Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and Hookworm
• A Single and Repeated Dose Escalation of RBD1016 in Subjects With Chronic Hepatitis B Virus (HBV) Infection
• Phase 3 Clinical Study Evaluating Nitric Oxide Nasal Spray (NONS) Efficacy To Treat and Prevent the Exacerbation of Infection in Individuals With Documented Asymptomatic or Mild COVID-19
• Evaluation of the Effects of Bradykinin Antagonists on Pulmonary Manifestations of COVID-19 Infections (AntagoBrad-Cov Study).
• Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection
• Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection.
• Utilizing the Crosstalk Among Aerosolized Phenformin , Methylene Blue, Photodynamic Therapy , Zinc and Potassium for Treating Severe COVID-19 Infection and Its Inflammatory Complication
• Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections
• Daily Zinc Supplement Effect on Prevention of Diarrhea and Acute Respiratory Infections in Children Less Than Five Years
• Clinical Study to Assess the Antiviral Properties of Echinaforce Reducing Oropharyngeal Concentration and Infectivity of SARS-CoV2
• Double Blind Randomized Clinical Trial of Use of Colchicine Added to Standard Treatment in Hospitalized With Covid-19
• Colistin Intravenous Administration in Critically Ill Patients Suffering From Hospital Infections Caused by Multi-antibiotic-resistant Germs.
• Study to Assess Safety and Efficacy of Lenacapavir and Emtricitabine/Tenofovir Alafenamide for Pre-Exposure Prophylaxis in Adolescent Girls and Young Women at Risk of HIV Infection
• Topical Vancomycin for Infection Prophylaxis in TJA
• Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection
• Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Receive
• In-patient COVID-19 Study of Intranasal Foralumab
• Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip
• Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
• A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection
• Third Dose of COVID-19 Vaccine in LTCF Residents
• Assessing Parenteral Antibiotics Versus Single-time Intra-operative Intra-dermal Antibiotic Administration for Prevention of SSI
• A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.
• Evaluation of the Efficacy of Prophylactic Topical Gentamicin in Tunnelled Catheters for Hemodialysis
• A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection
• Tobramycin Injection to Prevent Infection in Open Fractures
• Clinical Effectiveness and Bacteriological Eradication of 4 Short-course Antibiotics for Uncomplicated UTIs in Women.
• To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI
• Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly
• Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection
• Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection
• Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal Infection
• Study to Assess the Effectiveness and Safety of Lenacapavir for Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis
• Novel Experimental COVID-19 Therapies Affecting Host Response
• Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)
• Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection
• Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis
• Clinical Study of Efficacy and Safety of Rafamin in the Treatment of ARVI in Children 12-18 Years Old
• To Assess Use of Vancomycin Powder in Craniotomy on Wound Infection Rates
• Short Duration High Intensity Intrapleural Alteplase With Pulmozyme in Pleural Infection Management
• Comparison of Safety and Efficacy of de Novo Everolimus
• Letermovir Use in Heart Transplant Recipients
• Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals
• Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Disproxil
• Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)
• Antithrombin III in Infectious Disease Caused by COVID-19
• Zinc and Green Tea Extract for Community Respiratory Viral Infections
• Extended-infusion of Piperacillin-Tazobactam Versus Intermittent Infusion
• An Open-Label Study of Apabetalone in Covid Infection
• A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)
• EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform Trial
• Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults
• Comparison of Efficacy of Double Dose Oral Terbinafine Vs Itraconazole in Treatment of Dermatophyte Infections of Skin.
• Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems
• Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children
• Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV
• Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
• PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V
• Experimental Human Infection With Neisseria Gonorrhoeae (LptA Trial)
• Effectiveness of Colchicine Among Patients With COVID-19 Infection
• SARS-CoV-2 Human Challenge Characterisation Study
• Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection
• Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections
• A Study to Evaluate the Efficacy of Xlear vs. Placebo for Acute COVID-19 Infection
• Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection
• Effect of Vancomycin After Catheter Replacement
• Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection.
• Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia
• Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition
• A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients
• Evaluation of Transperineal Biopsy Under Local Anesthesia
• VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study
• PREvent Viral Exposure aNd Transmission Study: a SARS-CoV-2 PEP Study (PREVENT)
• Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria
• Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection
• Postoperative Antibiotics Following Primary and Secondary Breast Augmentation
• EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19
• Comparison of the Effects of 5%NaHCO3, 2%CHG and 70%Alcohol in the Prevention of Infections Related to Catheter
• Albuvirtide in Combination With 3BNC117 in Virologically Suppressed Subjects With HIV-1 Infection
• Transperineal vs. Transrectal MRI-targeted Prostate Biopsy
• Study to Evaluate the Safety and Efficacy of GS-5423 and GS-2872 in Combination With Lenacapavir (GS-6207) in Virologically Suppressed Adults With HIV-1 Infection
• DTG Plus 3TC for Prophylaxis of Mother-to-child Transmission of HIV Infection in Pregnant Women
• Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo
• Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects
• Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
• Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection
• Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients
• Conservative Treatment of Catheter - Related Injections With Gentamicine/EDTA
• Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts
• Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections
• Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection
• Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection
• Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients
• Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19
• Open-label, Follow-up of Doravirine/Islatravir for Participants With Human Immunodeficiency Virus -1 (HIV-1) Infection (MK-8591A-033)
• Comparison of Effectiveness and Complications of Catheter Lock Solutions in Non-tunneled Hemodialysis Catheters
• The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection
• Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection
• Efficacy and Safety of Colistin Based Antibiotic Therapy
• Study to Evaluate Safety and Activity of TRL1068 in Prosthetic Joint Infections
• Antiseptic Irrigation for Pleural Infection
• Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults
• Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19
• Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection
• The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection
• Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection
• Standard Antibiotic Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy
• Local Antibiotics for Breast Implants
• The DAWN Camostat Trial for Ambulatory COVID-19 Patients
• The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
• Or v IV Antibiotics for Infection
• Bismuth Quadruple Therapy With Cefuroxime for Helicobacter Pylori Eradication Treatment
• A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2
• Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection
• Efficacy and Mechanism of Action of Methenamine Hippurate (Hiprex™) in Women With Recurring Urinary Tract Infections.
• Use of Preoperative and Postoperative Antimicrobial Treatment
• A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection
• To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus Infection
• Pilot Clinical Trial - Comparative Study of Two Material Concentration of OD-141309
• Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents
• Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal
• Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19)
• Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.
• Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals
• Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
• Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
• Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections
• Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori Infection
• COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection
• Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)
• Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)
• Abbreviated Protocol for Two-Stage Exchange
• Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19
• LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies
• A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19)
• Camostat With Bicalutamide for COVID-19
• Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Have Sex With Men and Are at High Risk for HIV-1 Infection (MK-8591-024)
• Effectiveness of Rifabutin for Treatment of Helicobacter Pylori
• Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland
• CAR-T Cells for HIV Infection
• Anakinra in the Management of COVID-19 Infection
• A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19
• The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection
• A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection
• Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19
• Use of Angiotensin-(1-7) in COVID-19
• Evaluation of AHCC® for the Clearance of High Risk-HPV Infections in Chinese Female
• Effects of EDP-938 in Adult Hematopoietic Cell Transplant Recipients Who Are Infected With Acute Respiratory Syncytial Virus (RSV) of the Upper Respiratory Tract
• Surgical Site Infection and Antibiotic Use Study
• Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection
• Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection
• Quadruple vs Tailored Therapy in the Treatment of Helicobacter Pylori Infection
• Comparison of Three Antibiotic Protocols in Prevention of Infection in Dental Implant Surgery
• IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation
• Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia
• Preventing Urinary Tract Infections With E. Coli Nissle:
• CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients
• Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19)
• Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients
• Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?
• Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection
• Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)
• Topical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA
• Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient
• Difference of Surgical Site Infection Between Using Sodium Picosulfate Solution(PicosolutionⓇ) and Oral Sulfate Tablet(ORA·FANGⓇ) in Colorectal Cancer Surgery
• GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)
• Mouth Rinses for Inactivation of COVID-19
• OD-doxy-PNV-COVID-19 Old Drug " DOXY " for Prevention of New Virus " COVID-19 "
• Efficacy of Nicotine in Preventing COVID-19 Infection
• A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)
• Utility of Single-dose Oral Antibiotic Prophylaxis in Prevention of Surgical Site Infection in Dermatologic Surgery
• Impact of Non-surgical Periodontal Therapy on Oral and Gut Microbiome
• SSI Rates in Patients Undergoing Mastectomy Without Reconstruction- A Multicenter, Double-blinded RCT.
• Clinical Efficacy of Crano-cure inTreatment of Urinary Tract Infection
• Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19)
• Oral-only Antibiotics for Bone and Joint Infections in Children
• Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection
• A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
• PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)
• Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions
• Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection
• The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus in Treatment of BK Virus Infection in Kidney Transplantation Recipient
• BonE and Joint Infections - Simplifying Treatment in Children Trial
• Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
• Pegylated Interferon Lambda for Treatment of COVID-19 Infection
• Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19
• Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection
• Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
• Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection
• High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study
• A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19
• CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19
• Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
• Surgical Site Infection in Perforated Appendicitis After Peritoneal Lavage With Super-oxidised Solution
• Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection
• A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
• Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy
• Topical Vancomycin Over Sternal Edge in Cardiac Surgery
• To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia
• A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff
• Ofloxacin Concentration-toxicity Relationship in the Elderly
• Clazakizumab vs. Placebo - COVID-19 Infection
• A Study to Evaluate Effects of Proton-pump Inhibitor on Acalabrutinib Capsule When Administered Orally With COCA-COLA in Healthy Participants
• Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae
• Sildenafil in COVID-19
• Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection
• Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection
• SPI-1005 Treatment in Moderate COVID-19 Patients
• SPI-1005 Treatment in Severe COVID-19 Patients
• Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial
• Bictegravir/FTC/TAF for the Treatment of Primary HIV Infection
• Trial of Combination Therapy to Treat COVID-19 Infection
• Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection
• Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
• Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831
• Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection
• Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19
• Reducing Asymptomatic Infection With Vitamin D in Coronavirus Disease
• A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment
• Antiviral Agents Against COVID-19 Infection
• Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)
• Efficacy and Safety of Sirolimus in COVID-19 Infection
• A Study of Combination Therapies to Treat COVID-19 Infection
• Immunization With BCG Vaccine to Prevent Tuberculosis Infection
• NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection
• COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-Co
• Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection
• An Adaptive Clinical Trial of Antivirals for COVID-19 Infection
• Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection
• Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).
• Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection
• Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection
• Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease
• A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19
• Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients
• Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)
• Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 50 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)
• STerOids in COVID-19 Study
• Bezlotoxumab Efficacy and Tolerability in Cancer Patient
• Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19
• Hydroxychloroquine to Prevent SARS-CoV-2 Infection/COVID-19
• Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection
• Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease
• Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19
• D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)
• Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum
• P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19
• GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19)
• Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease
• A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19
• Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"
• Prophylactic Antibiotics for Surgical Site Infections and Beta-Lactam Allergy
• Short Therapy for Febrile UTI in Childhood
• Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)
• Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early
• Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19
• A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection
• Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19
• Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection
• Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial
• Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection
• PROphylaxis for paTiEnts at Risk of COVID-19 infecTion
• Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)
• Study on the Use of Sarilumab in Patients With COVID-19 Infection
• Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection
• Hyperimmune Plasma in Patients With COVID-19 Severe Infection
• Ropeginterferon Alfa-2b (P1101) Phase 3 Study in Interferon Treatment-Naive Subjects With HCV Genotype 2 Infection
• Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants
• A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19
• Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)
• Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection
• Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients
• Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T)
• Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection
• A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers
• Fluoxetine to Reduce Intubation and Death After COVID19 Infection
• PET/CT Imaging in COVID-19 Patients
• Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia
• A Study of N-acetylcysteine in Patients With COVID-19 Infection
• Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection
• Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection
• Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.
• Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
• Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection
• Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection
• The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection
• Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia
• Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection
• Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID)
• suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)
• Etoposide in Patients With COVID-19 Infection
• Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation
• Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.
• Pharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural Infections
• Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection
• Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection
• Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection
• Honey & Nigella Sativa Trial Against COVID-19
• CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort
• Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection
• Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection
• Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus
• A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection
• Pyridostigmine in Severe SARS-CoV-2 Infection
• Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.
• The Role of Resistant Starch in COVID-19 Infection
• Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection
• University of Utah COVID-19 Hydrochloroquine Trial
• Does Teicoplanin Powder Use In Lumbar Instrumentation Surgery Reduce Surgical Site Infection
• Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection
• CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection
• Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection
• Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction
• Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection
• Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED
• Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection
• DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old
• Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection
• Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Patients
• A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
• Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel
• A Study of Quintuple Therapy to Treat COVID-19 Infection
• Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection
• Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers
• Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease
• Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection
• Protective Role of Inhaled Steroids for Covid-19 Infection
• Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection
• EPICOS Clinical Trial for the Prevention of Infection in Healthcare Personnel
• ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic
• Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)
• The Vietnam Chloroquine Treatment on COVID-19
• Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers
• ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection
• Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection
• Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death
• Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients
• Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI)
• Escin in Patients With Covid-19 Infection
• Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)
• Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)
• The Impact of Camostat Mesilate on COVID-19 Infection
• A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
• Open Label Extension (OLE) of the TDF2 Study, Botswana
• Norwegian Coronavirus Disease 2019 Study
• The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection
• NO Prevention of COVID-19 for Healthcare Providers
• Losartan for Patients With COVID-19 Requiring Hospitalization
• Losartan for Patients With COVID-19 Not Requiring Hospitalization
• Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites
• Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects
• Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2
• Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection
• Effect of Nanotechnology Structured Water Magnalife for the Prevention of Recurrent Urinary Tract Infections.
• Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
• Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19
• 24 Vs 48 Hours of Cefazolin or Cefuroxime as Prophylaxis
• Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection
• Oral Versus Intravenous Antibiotics for the Treatment of Pleural Space Infection: a Randomized Controlled Pilot Trial
• Biktarvy in Treatment-Naïve Late Presenters With HIV-1 Infection
• Doravirine/Islatravir (DOR/ISL) in Pediatric Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are <18 Years of Age and Weigh ≥35 kg (MK-8591A-028)
• Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection
• The Clinical Study of Carrimycin on Treatment Patients With COVID-19
• Antibiotic Bladder Instillations vs. Oral Suppression for the Treatment of Recurrent Urinary Tract Infections
• Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment
• TRA for Preventing Symptomatic Urinary Tract Infection Among High-risk Elderly Residing in Nursing Homes
• Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals
• Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV
• Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection
• Vitamin C for the Prevention of UTI in Women Who Undergo Elective Gynecological Surgeries
• Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds
• Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery
• Triclosan-antibacterial Sutures Impact on the Incidence of Surgical Site Infection in Clean-wounds
• Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)
• The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection
• ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection
• Gentamicin Intravesical Efficacy for Infection of Urinary Tract
• Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure
• Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection
• Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds
• Defining the PrEP Care Continuum Among Recently Incarcerated Men at High-Risk for HIV Infection
• Topical Gentamicin and Vancomycin for Vascular Surgical Site Infection Prophylaxis
• First-in-human Study of VE303 in Healthy Adult Volunteers
• Properties of Absorbable and Nonabsorbable Suture Material in Dental Surgery
• Randomized, Double-blind, Efficacy, and Safety Study of Doravirine/Islatravir (DOR/ISL) in Treatment-naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)
• D-PLEX 311: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection
• Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019)
• Oral Corticosteroids for Post-infectious Cough in Adults
• A Study of AK0529 in Chinese Infants Hospitalized With RSV
• A Study in Infants With RSV LRTI to Evaluate RV521
• Treatment of Low Dose IL-2 and Ganciclovir in Cytomegalovirus Infection
• Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation.
• Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Patients
• Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection
• Nasal Decolonization of Dialysis Patients Noses
• A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection
• Fixed-dose Amikacin for Elderly UTI
• Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery
• Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)
• Inflammation and Co-Infections in D²EFT
• Atezolizumab Plus Bevacizumab With HCC and HBV Infection
• Enhancing Nutrition and Antenatal Infection Treatment for Maternal and Child Health in Ethiopia
• Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection
• Study to Evaluate the Safety and Efficacy of Lenacapavir in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance
• Multicenter Study to Evaluate Efficacy, Tolerability, Safety of Derinat
• Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection
• Post-procedure Antibiotic Prophylaxis for Cardiac Electrical Device Implantation: ABxFREE Study
• Nasal Decolonization for Orthopedic Trauma Patients
• Omadacycline Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis
• Ceftriaxone as Home IV for Staph Infections
• Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection
• MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042)
• Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants.
• Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma
• Treatment of Mild-moderate Clostridium Difficile Infection (CDI)
• Safety and Pharmacokinetics of Rezafungin
• Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis
• The Use of A Prebiotic to Promote a Healthy Gut Microbiome in Pediatric Stem Cell Transplant Recipients
• Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection Patients
• Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.
• Alternative Prophylaxis in Female Recurrent Urinary Tract Infections
• Risk of SDRs Under 3HP and 1HP Regimen for LTBI
• PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV
• Effects of Phenoximethylpenicillin, Amoxicillin and Amoxicillin-clavulanic Acid on the Gut Microbiota
• Pharmacokinetics of Valacyclovir Oral Solution in Children
• The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing in Elderly Women With Recurrent UTI
• A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection
• PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT)
• RPV+DRV/Cobi Dual Therapy in Subjects With HIV Controlled Infection
• Immediate Versus Delayed Treatment of Odontogenic Infections
• Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)
• Reduction of Postoperative Wound Infections by Antiseptica?
• Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP
• Immunomodulation Therapy for Urinary Tract Infections
• Chlorhexidine vs. Iodine for Vaginal Preparation in Urogynecologic Procedures
• Short Post-surgical Antibiotic Therapy in Spine Infections - a Prospective, Randomized, Unblinded, Non-inferiority Trial
• Improving Dosing of Vancomycin in Young Infants With Infections
• Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection
• Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections
• Comparison Between Quadruple Regimens for Helicobacter Pylori Infection in Egypt
• Chemotherapy w/wo WeiLeShu in Metastatic Colorectal Cancer
• A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)
• Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection
• Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients
• A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection
• Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal Fusion
• Transplantation Using Hepatitis C Positive Donors, A Safety Trial
• A Community-based Intervention Among Active Drug Users in Montpellier
• A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)
• Efficacy and Safety of Teicoplanin in CDAD
• Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016)
• Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection Patients
• Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI)
• Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii
• NICU Antibiotics and Outcomes Trial
• Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against Hookworm
• Postoperative Antimicrobial Prophylaxis Versus Placebo for Infection Prevention in HCC After Liver Resection
• Dalbavancin Outpatient Pilot
• New Therapies and Biomarkers for Chagas Infection
• Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men
• Penn Microbiome Therapy for Recurrent Clostridium Difficile Infection
• PMT for Severe-CDI
• Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)
• TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection
• Preoperative Decolonization and Surgical Site Infections in Orthopaedic Surgery - 2 Year Outcome in Prosthetic Surgery
• Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries
• A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children
• Reducing INfection at the Surgical SitE With Antibiotic Irrigation During Ventral Hernia Repair (RINSE Trial)
• PWID; Longitudinal S Aureus Colonization Pattern and the Impact on Infection Frequency by Regular Showers With Chlorhexidine
• Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)
• Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)
• Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections
• Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)
• Preventing Young Infant Infections Using Azithromycin in Labour (PreYIAL) Trial
• Effect of Administration of 3rd Generation Cephalosporin on the Digestive Carrying of 3rd Generation Cephalosporin-resistant Enterobacteriaceae (CEF-IMPACT)
• Comparison of the Efficacy of Intravenous Paracetamol and Ibuprofen in the Treatment of Fever Due to Upper Respiratory Tract Infection
• Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection
• Phase I Study of Treatment for Persistent Infection With HPV-16
• The Effect of Early Treatment of PC945 on Aspergillus Fumigatus Lung Infection in Lung Transplant Patients.
• Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection
• Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)
• Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae
• Vancomycin Powder Combined With Autogenous Bone Graft as a Prevention for Post-operative Infection for Spine Surgery
• Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection
• Antiretroviral Therapy for Acute HIV Infection
• Azithromycin-Prevention in Labor Use Study (A-PLUS)
• RCT Cefiderocol vs BAT for Treatment of Gram Negative BSI
• Clinical Efficacy of Fosfomycin Trometamol Per os in the Treatment of Documented Male Urinary Tract Infections With ESBL-producing Enterobacteriaceae With ESBL Producing Enterobacteriaceae and Resistance Associated With Fluoroquinolones and Cotrimox
• Inulin for Infections in the Intensive Care Unit
• Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection
• Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women
• P.Acnes Colony Count Following Subdermal Cefazolin
• Raltegravir One Thousand Two Hundred vs Darunavir-cb in Immnunosupressed Patients: ROTDIP Study
• Experimental Human Infection With Neisseria Gonorrhoeae
• Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections
• Evaluating the Efficacy and Safety of Intra-wound Vancomycin Powder in High Risk Patients
• Evaluation of Efficacy and Safety of Gynomax® XL Ovule
• ROSSINI 2 - Reduction of Surgical Site Infection Using Several Novel Interventions
• Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV
• Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women
• Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection
• Intraluminal Mono-antibiotic Therapy for Helicobacter Pylori Infection - A Comparison of Levofloxacin Powder and Levofloxacin Solution
• Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)
• ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI
• Clinical Trials to Assess the Efficacy and Safety of HLIM
• Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection
• Urinary Track Infection Prevention After Urogynecological Surgery
• Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
• Safety and Efficacy of NF135 CPS Immunization
• Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections
• Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
• Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons
• Fecal Transplantation for Primary Clostridium Difficile Infection
• Triple or Quadruple Combination DAAs Treatment for Subjects With HCV GT 1b Infection
• Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
• Phase 2 Study of VE303 for Prevention of Recurrent Clostridium Difficile Infection
• Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals
• Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection
• A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection
• Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection
• Topical Silver Nanoparticles for Microbial Activity
• A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection
• Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection
• Efficacy and Tolerance of 4 Weeks of Tedizolid in Prosthetic Joint Infections Treated With Implant Removal
• Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds
• Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in Adults
• Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection
• Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection
• Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation
• Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus
• Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects
• Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants
• Establish the Relationship Between Shift in Prescribing Pattern and Associated Shift in Sensitivity Pattern of Causative Microbes in UTI Patients in a Closed Community
• Anti-viral Effect of PC786 on RSV Infection on HSCT Recipients
• Empiric Treatment for Acute HIV in the ED
• Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections
• Does Antibiotics Use During Surgery Help to Decrease Wound Infection and Increase Success After Ear Surgery in Children
• FALCON Trial Testing Measures to Reduce Surgical Site Infection
• Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients.
• Anti-RSV Study in Chinese Patients (ASCENT)
• Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)
• A Safety and PK Study of IV Eravacycline
• A Clinical Trial to Evaluate the Efficacy and Safety of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide as a First-line Treatment in Naïve Patients With HIV-1 Infection With Severe Immunosuppression
• A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model
• Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections
• Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
• t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection
• PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)
• to Evaluate the Efficacy and Safety of Eltrombopag for Thrombocytopenia With Chronic HBV Infection
• Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection
• A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection
• Clinical Study of Sanjin Tablets for the Treatment of Acute Simple Lower Urinary Tract Infection
• Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection
• Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)
• Vaginal Preparation With Chlorhexidine-alcohol vs. Povidine-iodine vs. Saline
• Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa
• Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment
• D-PLEX 310: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection
• Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
• The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation
• Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients
• Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection
• Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection
• Less Infections for the Diabetic Foot
• Treatment of Strongyloides Infection
• Short vs. Long Antibiotic Treatment of Implant-free Osteoarticular Infections
• Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection
• A Study in Healthy Volunteers
• Antibiotic Prophylaxis in Clean Surgery. Impact on Surgical Site Infection
• To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
• Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
• A Single Ascending Dose Study of BTZ043
• Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of SH229 in Patients With HCV Infection
• Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options
• Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria
• Study the Efficacy of Topical Antibiotherapy in the Prophylaxis of Incisional Surgical Infection in Urgent Surgery
• Comparison of Therapy in Treatment of Patients With Helicobacter Pylori Infection: Concomitant Versus Hybrid Therapy.
• Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.
• Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)
• Arresting Vertical Transmission of Hepatitis B Virus
• Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection
• A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection
• Randomized Trial of 2% Chlorhexidine-70% Isopropanol vs 5% Povidone Iodine-69% Ethanol for Skin Antisepsis in Reducing Surgical-site Infection After Cardiac Surgery
• D-PLEX 302: Efficacy and Safety of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery
• Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients
• Genotypic Resistance Guided Therapy for Refractory H. Pylori Infection
• The Effect of Oral Antibiotics on Synovial Fluid and Differential for the Diagnosis of Infection
• Measures for the Prevention of Surgical Site Infection
• Subcutaneous Tissue Irrigation With Povidone Iodine in Decreasing the Rate of Surgical Site Infection Following Cesarean Section
• Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy
• Temocillin Versus a Carbapenem as Initial Intravenous Treatment for ESBL Related Urinary Tract Infections
• Azithromycin Compared With Doxycycline for Treating Anorectal Chlamydia Trachomatis Infection Concomitant to a Vaginal Infection
• Rifaximin for Infection Prophylaxis in Hematopoietic Stem Cell Transplantation
• Intraluminal Metronidazole Powder Monotherapy for Helicobacter Pylori Infection
• Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
• Intraluminal Amoxicillin Powder Monotherapy for Helicobacter Pylori Infection
• Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection
• Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection
• Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection
• Risk of Tuberculous and Other Infections in Patients of Spondyloarthritis Treated With Tofacitinib in Bangladesh
• Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury
• Preventing Recurrent Urinary Tract Infections With α-D-mannose
• A Unique Regimen for Treatment of Helicobacter Pylori Infection
• Cantharidin and Occlusion in Verruca Epithelium
• Phase 3 Study of Yimitasvir Phosphate Capsules
• Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam
• CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria
• Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission
• Fibrinolysis Compared to Thoracoscopy for Pleural Infection
• Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics
• Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection
• Phase 2 Study of Yimitasvir Phosphate Capsules
• Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections
• Controlled Human Malaria Infection Model for Evaluation of Transmission-blocking Interventions - Study 2
• Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea
• Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal
• Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections
• Effect of Vitamin E-containing Dressing on Surgical Site Infection in Colorectal Surgery
• Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis
• XC8 in the Treatment of Patients With Acute Respiratory Viral Infection
• Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units
• Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults
• Tailored Therapy for Clarithromycin-Resistant H. Pylori
• A Novel Regimen to Prevent Malaria and STI in Pregnant Women With HIV
• Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection
• Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections
• Preoperative Application of Chlorhexidine to Reduce Infection With Cesarean Section After Labor
• Pilot Trial of Inhaled Molgramostim in Nontuberculous Mycobacterial (NTM) Infection
• Microbiological Assessment After Chemo-Mechanical Caries Removal Using Papain-based Enzyme Versus Conventional Rotary Tools in Occlusal Carious Lesions
• Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
• Single- Versus Multiple-dose Antimicrobial Prophylaxis for The Prevention of Infectious Complications Associated With Peroral Endoscopic Myotomy(POEM) for Achalasia
• Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection
• Prevention of Infections in Cardiac Surgery (PICS) Prevena Study
• Preadmission Skin Wipe Use for Surgical Site Infection Prophylaxis in Adult Orthopaedic Surgery Patients
• Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection
• Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections
• Nutraceutical Efficacy for rUTI
• RESIST-2: 2nd-line ART for HIV-2 Infection
• Oral Nystatin Prophylaxis to Prevent Systemic Fungal Infection in Very Low Birth Weight Preterm Infants
• Antibacterial-coated Sutures at Time of Cesarean
• Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4
• Elbasvir (EBR)/Grazoprevir (GZR) in Pediatric Participants With Chronic Hepatitis C Infection (MK-5172-079)
• Tedizolid Prolonged Treatment for Prosthetic Joint Infections
• LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cUTI)
• Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly
• Hospital Avoidance Strategies for ABSSSI
• Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)
• Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)
• Avelumab With Valproic Acid in Virus-associated Cancer
• Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults
• LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)
• Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women
• Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System
• Placebo-Controlled Trial of Antibiotic Therapy in Adults With Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin Level
• Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120)
• Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With
• A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection
• A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.
• Pyridostigmine as Immunomodulator in People Living With HIV
• Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RA
• A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
• Study for Antibiotic Impregnated Calcium Sulfate Beads as Prophylaxis for Surgical Site Infection
• Asymptomatic Congenital CMV Treatment
• INtravesical Antimicrobial Agents v STANDard Oral Antibiotics for the Treatment of Acute UTI in Women With rUTI
• Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)
• Effect of Alfacalcidol to Respiratory Infection and Immune Response of Indonesian Elderly
• Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery
• Triple Combinations Against Hookworm Infections in Lao
• Effect of Antibiotics on Gut Microbiome and Plasma Metabolome
• EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
• Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
• Mebendazole Study Against Hookworm Infections in Children and Adolescents in Ghana
• Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection
• Safety, Pharmacokinetics and Antiviral Activity of RV521 Against RSV
• Ethanol-lock Therapy for the Prevention of Non-tunneled Catheter-related Infection in Pediatric Patients
• YCFM (Youth Correctional Facilities Males)
• Reduction of Intravenous Antibiotics In Neonates
• Microbial Colonization and Change of Chronic Keratinized Hand Eczema After Using Halometasone Triclosan
• Pharmacological Comparison of Continuous and Intermittent Infusions of Cloxacillin
• Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)
• PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection
• CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections
• Perioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant Recipients
• Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunode
• Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
• A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)
• MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)
• Tumescent Anesthesia Antibiotic Delivery (TAAD)
• A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human
• Safety and Efficacy of 2 Treatment Regimens of Aztreonam for Inhalation Solution in Children With Cystic Fibrosis and New Onset Pseudomonas Aeruginosa Infection
• A Pharmacokinetic Study of Tedizolid Phosphate in Pediatric Participants With Gram-Positive Infections (MK-1986-014)
• MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)
• Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on ART
• Sequential Versus Quadruple Therapy in the Second-line Treatment
• Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
• Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.
• Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
• Topical Antibiotic Prophylaxis for Eyelids
• ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator
• Efficacy and Safety of Oral Encochleated Amphotericin B for the Treatment of Cryptococcal Infection
• Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections
• ECOSPOR IV: An Open-Label Extension of Study SERES 0012 Evaluating SER-109 in Subjects With Recurrent Clostridium Difficile Infection
• ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection
• Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001)
• A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)
• A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection
• Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection
• The Effects of a Synbiotic Addition on Eradication Therapy of Helicobacter Pylori Infection in Children
• UB-421 Combine With Optimized Background Therapy Regimen in Multi-Drug Resistant HIV-1 Infection Patients
• Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections
• Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract Infections
• Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV)
• Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant Pathogens
• Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial
• Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study
• Bacteriophages for Treating Urinary Tract Infections in Patients Undergoing Transurethral Resection of the Prostate
• Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections
• 10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication
• Effectiveness of Alcohol Swabs for Preventing Infections During Vaccination
• Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV
• Intraluminal Therapy for Helicobacter Pylori Infection
• Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection
• Novel Gallium 68 Citrate in Orthopedic Infections
• Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization
• The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials
• Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection (MK-5172-096)
• Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff
• Phase 2B/3 Double-blinded Placebo-controlled
• The ICON Study: Outcomes After FMT for Patients With IBD and CDI
• Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion
• Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection
• Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria
• Effect of a Combination of Bundles on Surgical-site Infection After Elective Colorectal Surgery
• Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection
• Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects
• N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis
• Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous
• Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
• Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children
• Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children
• Twice Yearly Treatment for the Control of LF
• Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections
• FEcal Transplant, a Hope to Eradicate Colonization of Patient Harboring eXtreme Drug Resistant Bacteria?
• A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus Infection
• Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection
• Dolutegravir and Darunavir Evaluation in Adults Failing Therapy
• Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections
• CMV-CTL for the Treatment of CMV Infection After HSCT
• Cryptococcal Antigen Screening Plus Sertraline
• Autologous Cord Blood Mononuclear Cells for Bronchopulmonary Dysplasia in Very Preterm Neonates
• Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis
• Screening to Prophylax Against Clostridium Difficile Infection -
• Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis
• National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection
• Immediate Versus Delayed Induction in Term-PROM Using or Not Antibiotic Prophylaxis
• Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection
• Kinetics of HIV-RNA Decay in Seminal Plasma of Men Treated by Dolutegravir at the Time of Primary HIV Infection
• Metformin Therapy in HCV Infection
• An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection
• Echinacea Junior vs Vitamin C in Children 4-12 Years Old
• Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
• A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection
• Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
• Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract Infections
• 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection
• Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics
• Alcoholic Chlorhexidine Compared to Povidone Iodine to Limit Perineural Catheter Colonisation
• Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
• Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children
• Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy
• Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI
• Swabbing of Subcutaneous Tissues of Cesarean Section Wounds With Povidone Iodine
• Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy
• MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)
• Early ART to Limit Infection and Establishment of Reservoir
• Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE)
• Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection
• SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence
• Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2
• Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults
• A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection
• Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen
• Effect of Vitamin E Ointment on Incisional SSI in Colorectal Surgery
• Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
• Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.
• Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates
• E. Coli Nissle 1917 - Suspension for Infection Prophylaxis
• Recombinant Human Interferon a-2b Gel for HPV-16 and/ or HPV-18 Gynecological Infections
• The Preventive Infection Role of One Week Antibiotics Before Minimally Invasive Upper Tract Lithotomy
• Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections
• A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI)
• Sovaldi-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical Practice
• Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant
• Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Participants With Chronic Genotype 3 HCV Infection and Cirrhosis
• Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection
• LAW Trial -The Impact of Local Anesthetics Infiltration in Surgical Wound of Gastrointestinal Procedures
• Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.
• Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections
• A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)
• Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis
• Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection
• Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013)
• Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV Infection
• A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
• RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
• Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection
• Trial of Post-Dated Delayed Antibiotic Prescriptions
• An Efficacy and Safety Study of Theraflu Night Powder as Oral Solution for Cold and Flu
• Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients
• Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014)
• Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery
• A Trial to Assess Safety and Efficacy of Topical MBN-101 in Patients With Moderate/ Severe DFI
• Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus Infection
• Study of Antiretroviral Therapy to Prevent HBV Intrauterine Infection
• Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study
• Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis
• Surgical Site Infections After Liver Transplantation Based on Perioperative Antibiotics
• A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection
• Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
• Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection
• Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection
• Phase 2, Multiple Ascending Dose Proof of Concept Study
• Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
• Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafena
• Acupuncture for Prevention of Recurrent Urinary Tract Infections.
• Antiseptic-coated Intermittent Urinary Catheter
• Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subjects
• A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent Infections
• Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection
• Pharmacodynamics Modeling to Optimize Dosage Regimens of Sulbactam in Patients With Acinetobacter Infections
• Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
• Effect of Peri-operative Supplemental Oxygen in Wound Infection After Appendectomy
• Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection
• Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae
• A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections
• An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and Flu
• Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence
• Clinical and Virological Efficacy of Pegylated Interferon Alpha in the Treatment of Rhinovirus Infection in Patients With Primary Hypogammaglobulinemia: Randomized Controlled Trial
• Metformin Immunotherapy in HIV Infection
• Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
• Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection
• Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE)
• Viral Inhibition in Children for Treatment of RSV
• Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection
• Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection
• Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o.
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection
• Efficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs
• Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and Cirrhosis
• Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor
• Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers
• Clindamycin-rifampin Drug Interaction in the Treatment of Bone and Joint Infections
• The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)
• Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis
• Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections
• Intravenous Versus Combined Oral and Intravenous Antimicrobial Prophylaxis for the Prevention of Surgical Site Infection in Elective Colorectal Surgery
• Impact of Vitamin D Supplementation on Recurrent Respiratory Infections in Paediatric Primary Care.
• Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
• Infant TB Infection Prevention Study
• Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection
• Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy
• Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy
• Skin and Soft Tissue Infection (SSTI) Study
• EVRIOS : Comparative Evaluation of Low Versus High Doses of Rifampicin
• Yallaferon in Chinese Population
• A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection
• A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection
• Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection
• Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection
• A Multiple Dose Study of the Safety, Tolerability and PK of CMX157 in Healthy Subjects
• Switching Regimen in Treating Cirrhotic HCV GT1b Subjects
• A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection
• Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA
• Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis
• Targeting Platelets in Chronic HIV Infection
• Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution
• Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients
• Staph Household Intervention for Eradication (SHINE)
• Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
• FMT for Moderate to Severe CDI: A Randomised Study With Concurrent Stool Microbiota Assessment
• Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections
• A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) Infection
• Prolonged Infusion Cefepime and Nosocomial Infections
• Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence
• A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI
• Comparative Effectiveness of 30%TSC and Heparin Lock Solution in Hemodialysis Catheters
• Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection
• Preoperative Decolonization and Surgical Site Infections - a Prospective Randomized Trial
• DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO)
• High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection
• Early Simplified: A Trial to Compare the Efficacy of Standard of Care Combination Antiretroviral Therapy With a Simplified Dolutegravir Monotherapy in Patients With a Primary HIV-1 Infection
• Personalized Treatment for Refractory H Pylori Infection
• Comparison of Two Rescue Therapies for Helicobacter Pylori Infection
• Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection
• A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection
• Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection
• Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral Regimen
• Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection
• ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis
• ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection
• Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children
• A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
• Skin Prep to Reduce Postoperative Shoulder Infection
• Pharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit
• Meropenem Penetration Across BBB in Patients With CNS Infection and Optimization of Meropenem Treatment
• Parenteral Antibiotics Compared to Combination of Oral and Parenteral Antibiotics in Colorectal Surgery Prophylaxis
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcin
• Tumescent Antibiotic Delivery for Prevention of Surgical Site Infection
• Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)
• A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract Infection
• Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection
• 2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery Patients
• Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection
• Prevention of Post-operative Urinary Retention
• A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)
• A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects
• Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection
• Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection
• Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection
• Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients
• Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine
• Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection
• Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).
• Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli
• SOF Plus DCV in Treating Chinese Treatment-experienced HCV Patients
• Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection
• Triple DAAs Regimen in Treating Non-cirrhotic HCV GT1b Subjects
• Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections
• Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection
• A Study of AK0529 in Infants Hospitalized With RSV
• Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection
• A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection
• A Study to Evaluate the Safety of a Single IV Dose of Orbactiv (Oritavancin) in Subjects on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
• Safety, PK and PD Study of ABX464 in Untreated HIV Patients
• Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
• Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)
• 18F-FDS PET/CT in Healthy Volunteers and Patients With Suspected Infection
• Daily Chlorhexidine Care at the Exit Site in Peritoneal Dialysis Patients
• Continuous Antibiotic Prophylaxis in Colorectal Surgery
• Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin
• A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil
• A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection With Levofloxacin Hydrochloride Tabl
• Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI)
• Expanded Access and Open Label Extension Study of SER-109 to Prevent Recurrent Clostridium Difficile Infection
• Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial Response
• A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses
• Study of Debio 1450 for Bacterial Skin Infections
• Antibiotic Treatment for 7 Days Versus 14 Days in Patients With Acute Male Urinary Tract Infection
• Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection
• The Influence of Antibiotic Prophylaxis on Intraoperative Prosthetic Joint Infection Cultures
• Randomized, Multicenter, Double-blind, Vancomycin-controlled Study to Evaluate the Efficacy of Ethanol Lock Solution for the Curative Treatment of Implantable Venous Access Port Infection Due to Coagulase-negative Staphylococci
• Steroids and Post-resuscitation Infectious (Septic) Complications
• Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection
• Freeze-dried, Capsulized FMT for RCDI
• Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults
• Chlorhexidine Versus Povidone-Iodine Antisepsis for Reduction of Post Cesarean Section Surgical Site Infection
• Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection
• Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117)
• Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection.
• Use of 2% Chlorhexidine Cloths Reduce Surgical Site Infections
• Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection
• Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants
• Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection
• Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection
• Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)
• Topical Use of Vancomycin in Reducing Sternal Wound Infection in Cardiac Surgery (SWI Trial)
• The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection
• Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection
• A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
• Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection
• GM-CSF to Decrease ICU Acquired Infections
• Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection
• The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection
• Short-course Methenamine Hippurate for Prevention of Post-operative UTI
• Effects of Antibiotic Prophylaxis on Recurrent UTI in Children
• A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection
• Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria
• Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients
• Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
• Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection
• Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection
• Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone
• HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection
• Vietnam Cryptococcal Retention in Care Study Version 1.0
• Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions
• To Study the Effect of Adjunctive Oral Methylprednisolone Therapy in Pediatric Urinary Tract Infection
• Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic A
• Efficacy of Polymyxin B Against Infections Caused by Extensively Drug-resistant (XDR) Gram-Negative Bacteria
• Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants
• A Study of Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections
• A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430
• HepNet Acute HCV IV - LDV/SOF FDC in Acute Genotype 1 Hepatitis C Virus Infection
• Multi-Center Study of New Medications to Treat Vaginal Infections
• Multi-Center Study of New Medications to Treat Vaginal Infections
• Multi-Center Study of New Medications to Treat Vaginal Infections
• The Use of Ceftaroline as Surgical Prophylaxis in Surgery With Risk of MRSA Infection
• Comparison of Multiple-, Single- and Zero-dose of Ciprofloxacin Prophylaxis in Retrograde Intrarenal Surgery
• Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia
• An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections
• IMT for Primary Clostridium Difficile Infection
• Surgical Infection Rates With Adjunct Vancomycin Compared to Standard Peri-Operative IV Antibiotics
• Comparative Effectiveness of Antibiotics for Respiratory Infections
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection
• A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
• Temocillin Pharmacokinetic in Hemodialysis
• Topical Vancomycin for Neurosurgery Wound Prophylaxis
• Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana
• MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants
• A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60
• Neonatal Package Study in Rural District of Pakistan
• ATAPAC Study (TauroLock Activity in Adult Cancer Patients)
• Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
• MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection
• Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
• Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
• Deescalating Carbapenems in Hospital Setting
• A New Supplement for the Immune Response to HPV Infection
• Temocillin Pharmacokinetics in Paediatrics
• A Randomised Trial of Dolutegravir (DTG)-Based Antiretroviral Therapy vs. Standard of Care (SOC) in Children With HIV Infection Starting First-line or Switching to Second-line ART
• Primary Prevention of Infections Related to Chambers Implantable Catheter by a Taurolodine Lock in Patients With Cancer Receiving Parenteral Nutrition
• FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI
• Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract
• Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
• Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection
• Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination +/- Ribavirin in Adolescents and Children With Chronic HCV-Infection
• HCV-HIV Co-infected Patient Cohort in Thailand
• Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt
• Recurrent Urinary Tract Infections and Heparin (RUTIH Trial)
• Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection
• REP 2139-Ca / Pegasys™ Combination Therapy in Hepatitis B / Hepatitis D Co-infection
• Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
• Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (VANCO)
• Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition
• Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis
• Wound Infections Following Implant Removal
• Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV Infection
• Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study
• Decreasing Infection In Arthroscopic Shoulder Surgery
• Ledipasvir/Sofosbuvir Fixed-Dose Combination on Cerebral Metabolism and Neurocognition in Treatment-Naive and Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection
• Study on the Impact of Triptolide Woldifiion on HIV-1 Reservoir In Acute HIV-1 Infection
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
• A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
• A Study to Evaluate Chronic Hepatitis C Virus (HCV) Infection in Cirrhotic Adults With Genotype 1b (GT1b) Infection
• L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection.
• Checklist to Prevent MRSA Surgical Site Infections
• Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients
• A Study of ALS-008176 in Infants Hospitalized With RSV
• Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.
• Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection
• Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection
• Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis
• Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy
• Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock
• Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen
• Antibiotic Irrigation for Pancreatoduodenectomy
• Efficacy and Safety Study of Metronidazole, Nystatin and Dexamethasone Combination Therapy in Bacterial and Fungal Vaginal Infections
• Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection
• S. Aureus Screening and Decolonization
• Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
• RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp.
• Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection
• Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection
• Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults
• A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
• Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP
• Safety and Efficacy Study of High Dose Colistin
• Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients
• Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection
• Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity
• Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli
• AUGMENTIN™ in Dental Infections
• Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
• Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection
• Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
• Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
• Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections
• Necessity of Antibiotics for Prevention of Delivery-associated Infections After Spontaneous Vaginal Delivery at Term
• Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
• Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
• Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C
• Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients
• Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis
• Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis
• A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients
• Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
• Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
• Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy
• Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068)
• Evaluation of the Role of Plasma Procalcitonin in Prediction of Intra-amniotic Infection in Preterm Premature Rupture of Membrane
• Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection
• Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy
• Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa Pneumonia
• Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.
• The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females
• A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model
• RCT: Triple vs Sequential vs Concomitant Therapy H Pylori
• Prophylaxis Of Wound Infections- Antibiotics in Renal Donation
• Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study. (CXL)
• Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection
• Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant
• Mecillinam for Treatment of Genital Chlamydia Infection
• Safety, Pharmacokinetics, and Pharmacodynamics of Ruzasvir (MK-8408) in Participants With Hepatitis C Infection (MK-8408-003)
• ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection
• Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV Infection
• Antibiotics and Gut Microbiota Among Newborn Infants
• Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children
• Enhancement by Poly-ICLC During HIV-1 Infection
• Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
• Active Bathing to Eliminate Infection (ABATE Infection) Trial
• Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects
• Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory Infection
• OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
• Efficacy Study of Alanyl-glutamine Supplementation for the Treatment of C. Difficile Infection
• Study to Investigate the Pharmacokinetics and Safety of Cadazolid in Patients With Clostridium Difficile Infection
• Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
• AIDS 347: IL-6 Blockade in Treated HIV Infection
• Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections
• An Open-Label Trial Of Reduced- Dose Pylera, Amoxicillin, and Esomeprazole in the Treatment Of Helicobacter Pylori Infection
• Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic Bladder
• Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802
• Intravesical Instillation of Hyaluronic Acid to Decrease Incidence of Urinary Tract Infection
• The INFECIR-2 Albumin Prevention Study
• A Study to Assess the Efficacy and Safety of Mebendazole for the Treatment of Helminth Infections in Pediatric Participants
• Effect of Chlorhexidine on Bacteriuria
• Prevention of Infection in Closed Fractures: Cefazolin Versus Vancomycin
• Prevention of Surgical Site Infection After Cesarean Delivery
• Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) in Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection
• Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Participants With Chronic Genotype 1 HCV Infection
• Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection
• Posaconazole as Salvage Therapy for Aspergillus Pulmonary Infection.
• The Amputation Surgical Site Infection Trial (ASSIT)
• RCT of Postoperative Infections Following Caesarean Section Infections Following Caesarean Section
• Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)
• Ceftaroline in the Treatment of Bone and Joint Infections
• Pharmacokinetics Study of Intraperitoneal Administration of Daptomycin in Peritoneal Infection
• Antibiotic Safety (SCAMP)
• Randomized Study Comparing Pleural Drainage by Videothoracoscopy to Medical Drainage in Infectious Pleural Effusion
• Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients
• Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
• Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV Infection
• Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children
• ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
• Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections
• Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV Infection
• ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation
• A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)
• Comparison of Efficacy and Tolerability of Two Cough Syrups in Cough Due to Cold in Children.
• Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections
• Study Comparing Nitrofurantoin to Fosfomycin for Acute Urinary Tract Infection in Women
• Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents
• Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection
• Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency
• Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
• Preliminary Study of Dornase Alfa to Treat Chest Infections Post Lung Transplant.
• Efficacy Study of Mupirocin on Infection After Coronary Artery Bypass Grafting
• Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
• TD-1607 MAD Study in Healthy Subjects
• CLEARI (Clinical Efficacy Assessment on Recurrent Upper-Respiratory Tract Infections) Study
• Catheter Early Withdrawal or Maintenance in Sepsis or Septic Shock
• A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years.
• Treatment of Antenatal Chlamydia Infection
• Meropenem Dosage Strategy Based on PPK Model
• A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Viru
• Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV
• Anti-H. Pylori Effect of Deep See Water
• Non-antibiotic Prescribing for Acute Upper Respiratory Tract Infection
• A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.
• Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts
• Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients
• Cytotoxic T Cells to Prevent Virus Infections
• Fecal Microbiota Transplant for Relapsing Clostridium Difficile Infection in Adults and Children Using a Frozen Encapsulated Inoculum
• An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine
• Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection
• Antibiotics and Tissue Expanders in Breast Reconstruction
• Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
• A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc
• Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
• 15-day Sequential Therapy for Helicobacter Pylori Infection in Korea
• Gentamicin Bladder Instillation Trial
• Nasal Spray With Glucose Oxidase Preventing Common Cold in Pre-school Children
• Cranberry on Urinary Tract Infections
• Phase I Trial for Pharmacokinetic Characteristics of Factive 200mg Intravenous Formulation (Gemifloxacin 200mg) With Factive 320mg Tablet Formulation (Gemifloxacin 320mg)
• Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)
• Rosuvastatin to Decrease Residual Immune Activation in HIV Infection
• Efficacy of Antimicrobial Prophylaxis for Shock Wave Lithotripsy (SWL) on Reducing Urinary Tract Infection (UTI)
• A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vagin
• Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
• A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before
• A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults
• Sildenafil for PNTM Infection
• Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
• Human Rhinovirus Infection and Airway Remodeling Mediators
• A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
• Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections
• Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children
• Vaginal Estrogen With Pessary Treatment
• To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy
• Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation
• Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection
• Clinical Investigation of Erlotinib as an HCV Entry Inhibitor
• A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1a Infection
• The Effect of Tight Glycemic Control on Surgical Site Infection Rates in Patients Undergoing Open Heart Surgery
• Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection
• Recombinant Human Interferon a-2b Gel for HPV Gynecological Infections
• Efficacy of JUC as Hand Rub Evaluated by Using European Standard 1500
• An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections
• The Impact of Proton Pump Inhibitors on the Fecal Microbiome
• Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus
• Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
• Efficacy of Fosfomycin-Trometamol in Urinary Tract Infection Prophylaxis After Kidney Transplantation
• MRSA in a Trauma Population: Does Decolonization Prevent Infection?
• Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis
• Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin
• Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
• Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study
• Individualized vs. Household MRSA Decolonization
• Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
• D Mannose in Recurrent Urinary Tract Infections
• Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3
• A Multiple Ascending Dose Phase I Study of SB 9200 in Treatment Naïve Adults With Chronic Hepatitis C Infection
• Study to Evaluate a HIV Drug for the Treatment of HIV Infection
• Prevention of Bacterial Infections in Newborn
• Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV)
• Staphylococcus Aureus Bacteremia Antibiotic Treatment Options
• TD-1607 SAD Study in Healthy Subjects
• Tygacil Drug Use Investigation
• Ciprofloxacin for Prevention of BK Infection
• Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus
• Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan)
• Pharmacokinetics of Micafungin in Patients Intensive Care Unit
• The Efficacy of Chlorhexidine Gluconate Pre - Disinfection Scrubbing in Preventing Surgical Site Infections for Hepatectomy Patients
• A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
• Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 Infection
• Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections
• Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection
• Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants
• Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615)
• A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System
• Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection
• A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection
• Clinical Trial of Safety and Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adults
• Dose Escalation Trial of Intrasite Vancomycin Pharmacokinetics
• A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
• "Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients".
• Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection
• Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 (VITAL Infection)
• Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection
• Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection
• Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients
• Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients
• Pharmacological Study of High Doses of Ceftriaxone in Meningitidis
• Treatment of Recurrent Urinary Tract Infection (RUTI) by Traditional Chinese Medicine
• Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection
• Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients
• Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd Infections
• Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
• Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
• A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection
• First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers
• HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin
• A Study to Evaluate Chronic Hepatitis C Infection
• A Study to Evaluate Chronic Hepatitis C Infection in Treatment Experienced Adults
• Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum
• A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compens
• Povidone Iodine and Cesarean Section Wound Infections
• Evaluation of Safety Tolerability and Antiviral Activity of ACH-0143102 Plus RBV Treatment Naive HCV GT1b Subjects
• Comparison of Two Topical Formulations Containing Clindamycin and Clotrimazole in Patients With Vaginal Infections
• A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV Infection
• A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I Infection
• Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease
• Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir
• To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI)
• Palatability Testing of a New Paediatric Formulation of Valacyclovir
• Ethiopia Antimalarial in Vivo Efficacy Study 2012
• Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
• A Study to Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C
• A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection
• Use of Collatamp G Antibiotic Impregnated Sponges in the Treatment of Peri-prosthetic Total Joint Infections
• Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria
• WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8
• AV2 Antiviral Spray Versus Placebo in Human Papillomavirus Cervix Infections
• Boceprevir With Peginterferon Alfa-2b and Ribavirin in the Treatment-naive Patients Infected With Genotype 4 Chronic Hepatitis C Infection
• In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir
• Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection
• Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infect
• Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus
• Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens
• Additive Effect of Endonase on Eradication Rate of Second Line Therapy for HP Infection
• Trial of 2% Chlorhexidine Bathing on Nosocomial Infections in the Surgical Intensive Care Unit
• Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women
• Prevention of Arrhythmia Device Infection Trial (PADIT)
• Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients
• Observational Study of HIV Infection in Participants of Seroconvert During Dapivirine Vaginal Ring Trials
• H-IVIG Treatment for Severe H1N1 2009
• Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women
• Prevention of Arrhythmia Device Infection Trial (PADIT)
• Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
• Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia
• Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
• Evaluation of Extended Intravenous of Beta-lactams in the Treatment of Serious Gram-negative Infections in Critically Ill Patients
• Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
• The SCOUT Study: "Short Course Therapy for Urinary Tract Infections in Children"
• Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
• Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
• Phase 2a Study of CG400549 for the Treatment of cABSSSI Caused by Methicillin-resistant Staphylococcus Aureus
• Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients
• Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
• Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI
• A Study of the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected Patients
• Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
• Colistin and Rifampicin for MDR-Acinetobacter
• Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa
• Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Phenylephrine 10mg + Guaifenesin 200 mg Syrup in Patients Suffering a Upper Respiratory Tract Infection (URTI)
• Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
• An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation
• Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection
• Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections
• Post Marketing Surveillance Study on Linezolid
• Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection
• Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic Colitis
• Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection
• Fidaxomicin to Prevent Clostridium Difficile Colonization
• Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections
• Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under One
• 5 Day Concomitant Versus 10 Day Sequential Therapy for Eradication of H. Pylori Infection
• Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL)/AmpC Enterobacteriaceae
• A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes
• Diabetic Foot Infection Antibiotic Study
• Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)
• Increased Microcirculation for Preventing Postoperative Wound Infections in Patients Undergoing Reduction Mammoplasty
• Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections
• Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates
• Is it Effective to Treat Patients With Blastocystis Hominis Infection?
• A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci
• Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia
• A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)
• Examination of the Efficacy of Preventive Antibiotic Treatment During the Puerperium Among Pregnant Women With Recurrent Urinary Tract Infections
• Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)
• Safety, Tolerability, and Efficacy of MK-7655 (Relebactam) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for Treating Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
• Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women
• Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
• Respiratory Syncytial Virus - RSV Protocol
• Treatment of Methicillin-sensitive Staphylococcus Aureus (MSSA)
• Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections
• Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
• Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive
• Immediate vs. Conditional Use of Antibiotics in Uncomplicated Urinary Tract Infection (UTI) - ICUTI
• Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus
• Use of a Novel Catheter Lock Solution For Treatment of Hemodialysis Catheter Infections
• Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection
• Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) Infection
• Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)
• A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection
• On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men
• Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection
• The Skin Prep Study
• Prophylaxis of Gastrointestinal Infections With EcN
• Treating Hispanic Patients Diagnosed With Hepatitis C Using Boceprevir
• Placebo and Active Controlled Study to Compare the Antipyretic Efficacy of Aspirin® in Patients With Acute Febrile Upper Respiratory Tract Infections Suspected to be of Viral Origin
• Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China
• The Effect of Prolonged Postoperative Antibiotics Administration on Rate of Infection in Patients Undergoing Posterior Spine Surgery Requiring a Hemovac Drain
• Effectiveness of Triclosan Coated Sutures in Preventing Leg Wound Infection After Coronary Artery Bypass Surgery
• Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)
• Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI)
• Individualization of Ganciclovir and Valganciclovir Doses Using Bayesian Prediction in Renal Transplant Patients.
• Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal Infections
• DAS181 in Patients With Parainfluenza
• GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection
• Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant
• Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Study on Cefotaxime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
• TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
• Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
• Evaluation of Safety, PK and Immunomodulatory Effects of AB103 in Necrotizing Soft Tissue Infections Patients
• Evaluation of the Clinical Practice of Using of a 70% Ethanol Lock Solution for the Prevention of Catheter Related Blood Stream Infections in Pediatric Patients Undergoing Intestinal Rehabilitation
• Safety and Efficacy of PP4001 for the Treatment of Symptoms Associated With Uncomplicated Urinary Tract Infection
• Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
• Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections
• Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)
• Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years
• Efficacy and Safety of an Ethanol/Sodium Citrate Locking Solution: A Pilot Study
• Corticosteroids for Children With Febrile Urinary Tract Infections
• Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder
• Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection
• Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection
• GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
• GSK2251052 in Complicated Urinary Tract Infection
• A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
• Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
• Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061)
• Safety and Efficacy Study of Ethanol Locking to Prevent Central Line Infection in Premature Neonates
• Immunoglobulin Levels and Occurrence of Infections After Lung Transplantation and Impact of IgG Replacement
• Dornase Alfa Therapy for Ventilator Associated Lung Infections in the Neonatal Intensive Care Unit (NICU)
• Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot Study
• Comparative Efficacy of Different Mebendazole Polymorphs in the Treatment of Soil-transmitted Helminth Infections
• Asymptomatic Bacteriuria & Risk of Urinary Tract Infection in Renal Transplants
• 3-year Follow-up Study in Patients Previously Treated With TMC435-Containing Regimen for the Treatment of Hepatitis C Virus Infection
• Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study
• Preventing Urinary Tract Infection Post-Surgery
• Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
• Effectiveness and Safety of Tigecycline for Therapy of Infections Caused by Multi-Drug Resistant Acinetobacter Baumannii
• Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
• A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
• A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
• Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin
• Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex Workers
• The Efficacy of Five Anthelmintic Regimes Against Trichuris Trichiura Infections in Schoolchildren in Jimma, Ethiopia
• Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients
• Extension Study of Liposomal Amikacin for Inhalation in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (Pa) Infection
• Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa
• Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections
• Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects
• Prevention of Surgical Site Infections: Effectiveness of Nasal Povidone-Iodine and Nasal Mupirocin
• Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV)
• Study of Blood Levels of Ceftaroline Fosamil in Children Who Are Receiving Antibiotic Therapy in the Hospital
• Study to Evaluate Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery
• Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant
• Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir
• A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
• Lenalidomide in Kaposi Disease Associated With HIV Infection
• Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infections
• A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005)
• Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
• Study of SCY-635, Pegasys and Copegus in Hepatitis C
• Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel Syndrome
• Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3
• Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia
• Efficacy of Diclofenac Potassium vs Nimesulide in the Treatment of Fever and Pain in Children With Upper Respiratory Tract Infection
• Efficacy and Safety of Ertapenem Sodium (MK-0826) Following Colorectal Surgery in Chinese Adults (MK-0826-056)
• Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
• Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
• Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2
• Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
• A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1
• A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)
• Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion
• Tailored Antibiotics Prophylaxis for Percutaneous Endoscopic Gastrostomy
• Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
• Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections
• Efficacy of Two Prophylactic Schedules (Prulifloxacin Versus Phosphomycin)
• Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET)
• Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)
• Ethanol in the Prevention of Central Venous Catheter Infections
• Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin
• Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes
• A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
• Effect of Cranberry Extract on Infections in Burn Patients
• QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study.
• A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection
• Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD)
• HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir
• A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV)
• A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection
• Non-Inferiority of Gatifloxacin/Prednisolone Association vs Isolated Administration in Prevention of Ocular Infection/Inflammation
• A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection
• A Study to Assess the Efficacy of Raltegravir (Isentress®), Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145) (Wirksamkeit Von
• Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)
• Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus
• A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435
• GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
• Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
• Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection
• Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
• Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous Infusion
• Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection
• Use of 48 Hour Course of Antibiotics to Prevent Surgical Site Infection in Obese Patients Undergoing Cesarean Delivery
• A Multiple Ascending Dose Study of GS 5885 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
• A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures
• Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections
• Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting
• An Observational Study of Ertapenem in Outpatient Parenteral Antibiotic Therapy (OPAT) for Complicated Urinary Tract Infections.
• TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
• Molecular Detection of Antibiotic Resistance and H Pylori Eradication
• Loading Vancomycin Doses in the Emergency Department
• Effects of Intensive cART During Acute/Early HIV Infection
• Effectiveness for Interventions to Minimize Surgical Site Infections
• Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections
• Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "AG NPP709 Syrup"
• Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care Change
• Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections
• Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment
• Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection
• The Role of Cathepsin X in Infection With the Helicobacter Pylori
• Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection
• Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea
• Novel Interventions in HIV-1 Infection
• Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox)
• DCVax Plus Poly ICLC in Healthy Volunteers
• Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection
• Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily
• Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
• Evaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory Infection
• Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection
• Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin
• A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia
• A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
• A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
• Safety and Efficacy Study of a Non-antibiotic Treatment for the Eradication of Helicobacter Pylori
• PK of Tenofovir, Emtricitabine and Efavirenz in Healthy Volunteers
• Prevention of Catheter-Associated Urinary Tract Infection in Incontinence and Reconstructive Pelvic Surgery Patients
• Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees
• Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections
• Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment
• Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections
• Vitamin D Supplementation and Acute Respiratory Infection in Older Long-Term Care Residents
• Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies
• A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP)
• Efficacy and Safety of Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infections in Adults
• Mesalamine to Reduce T Cell Activation in HIV Infection
• HIV and Fat Accumulation
• A Multinational Trial of the Efficacy of Albendazole Against Soil-transmitted Nematode Infections in Children
• Sequential and Hybrid Therapies for H Pylori Infection
• Comparison Between Dexchlorpheniramine and Dexchlorpheniramine/Pseudoephedrine/Guaifenesin in Respiratory Infections
• Study of CB-183,315 in Participants With Clostridium Difficile Infection
• Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years
• Daptomycin as Antibiotic Prophylaxis of Sternal Wound Infections
• A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection
• Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status
• Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile Infections
• Recovery Time in Children With Lower Respiratory Tract Infections Treated With Klacid® Granules for Oral Suspension.
• Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections Treated With Klacid MR
• Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520)
• A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072
• Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus Infection
• Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
• Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection
• Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis
• A Pilot Study of the Effect of Minocycline on Cerebrospinal Fluid HIV-1 Infection
• Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo
• Study of Count Coughs in Subjects With Acute Upper Respiratory Tract Infections
• Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
• Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species Infection
• Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection
• HIV Treatment and CVD Events
• An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) Subject
• Evaluation of Body-worn Multimodal Hand Hygiene System. Impact on Health-Care Associated Infections
• A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections
• Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
• Symptomatic Therapy of Uncomplicated Lower Urinary Tract Infections in the Ambulatory Setting.
• In UTERO Treatment of Cytomegalovirus Congenital Infection With Valacyclovir
• Herpes Simplex Type 2 Co-infection in Veterans With Chronic Hepatitis C
• Evaluating the Use of Large-dose, Extended Interval Vancomycin Intravenous Administration for Skin and Soft Tissue Infections
• Study Evaluating The Efficacy Of A Novel Ibuprofen Formulation On Fever In Patients With An Uncomplicated Acute Infection
• Collaborative H1N1 Adjuvant Treatment Pilot Trial
• Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)
• The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection
• Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir
• Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease
• Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers
• A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
• A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
• A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients
• Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons
• Efficacy of Diclofenac Potassium Versus Acetaminophen in Febrile Children With Acute Upper Respiratory Tract Infections
• Effect of Socheongryong-tang and Yeongyopaedok-san in Upper Respiratory Tract Infection
• Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
• Trichomonas Vaginalis Recurrence Among HIV+ Women
• Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care in Japanese Patients (Pegylated-interferon Alpha-2a and Ribavirin)
• Pin Site Infection Prevention for Open Tibial Fracture
• Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha-2b and Ribavirin) in Japanese Patients
• Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections
• Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055)
• Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004)
• Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection
• A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)
• Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)
• Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1
• Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
• Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections
• PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region
• Efficacy of Acetilcysteine in 'Rescue' Therapy for Helicobacter Pylori Infection. Pilot Study
• Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV
• Cardiovascular Prevention for Persons With HIV
• Treatment Failure of Chlamydial Infection in Males and Females in Youth Correctional Facilities
• A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection
• Safety, Tolerability, and Antiviral Activity of ANA598 Administered in Combination With Pegylated Interferon and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection
• A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.
• Oral Versus Intravenous Antibiotics for Bone and Joint Infections (OVIVA B&J)
• Impact of Chronic Statin Use During Surgery on Inflammation and Infection Rates
• Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection.
• A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections
• Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I Infection
• Vitamin D, Blood Pressure, Lipids, Infection and Depression
• Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection
• A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)
• A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections
• A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
• Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
• Pediatric Ethanol Lock Therapy Study.
• Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections
• Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix
• Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration
• Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients
• Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients
• Compliance And Safety Study In Children With Upper And Lower Respiratory Tract Infections
• Antifungal Locks to Treat Fungal-related Central Line Infections
• Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial
• An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
• Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness
• Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
• Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections
• Prevention of Neurosurgical Wound Infections
• Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia
• Cross Linking for Treatment of Corneal Infection
• Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In Pediatric Subjects
• LEVOS - Levofloxacin and Rifampicin Therapy in the Treatment of OsteoArticular Prothethic Infection
• Low Dose Estriol With Lactobacilli Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women
• Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)
• Trial of Chinese Herbal Medicine in the Treatment of Upper Respiratory Tract Infections (URTIs)
• Efficacy and Safety of Single Versus Double Ritonavir-boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens
• Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection
• The Efficacy of Sequential Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection - A Pilot Study
• Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients
• Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection
• Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection
• Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
• Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus Infection
• Rifabutin Based Therapy for the Eradication of Staphylococcus Aureus Colonization in HIV Infected Adults
• Vitamin C for Prevention of Urinary Tract Infections in the Spinal Cord Injured
• Strategic Timing of Antiretroviral Treatment
• Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r
• Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC
• Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
• Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy
• Safety And Efficacy Of Maraviroc In Patients For HIV Patients (Regulatory Post Marketing Commitment Plan)
• Raltegravir Activity In Lymphoid Tissues
• Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?
• The Influence of Oral Hygiene on Local Wound and Systemic Infection in Patients With Percutaneous Endoscopic Gastrostomy Placement
• Buprenorphine/Raltegravir Pharmacokinetic Interaction Study
• Effectiveness and Safety of the of Guaifenesin, Doxylamine Succinate and Hydrochloride Etafedrine Syrup in Improvement of Symptoms Resulting From Acute Respiratory Infections.
• HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
• Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
• Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection
• Pharmacotherapy for HIV Infected Patients With Alcohol Problems
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus
• Safety of Acidform Lubricant in HIV-Uninfected Women
• Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection
• Treatment of Acute Hepatitis C Virus in HIV Co-Infection
• Effect of Maraviroc on Endothelial Function in HIV-Infected Patients
• Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care Unit
• Effect of Raltegravir on Endothelial Function in HIV-Infected Patients
• Role of Heme Oxygenase in the Pathogenesis of Hepatocellular Injury in Chronic Hepatitis C Virus (HCV) Infection
• Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
• Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection
• A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs
• Post-Authorization Study Evaluating Safety Of Tigecycline
• Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection
• Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir
• Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?
• The Efficacy and Safety of Dexibuprofen Syrup
• Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.
• Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551)
• Safety And Efficacy Of Rifabutin In HIV Patients
• Febrile Urinary Tract Infection Randomized Short Treatment Trial
• An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System
• An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida
• Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits
• Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection
• Benefit of a Single Preoperative Dose of Antibiotics for the Prevention of Surgical Site Infections
• Treatment and/or Prevention of Urinary Tract Infections
• Antiretroviral Therapy for Acute and Chronic HIV Infection
• Factorial Trial of Antimicrobial Therapy and/or Catheter Change for Catheter Urinary Tract Infections.
• A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections
• Probiotics for Girls With Recurring Urinary Tract Infections
• Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections
• Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)
• A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)
• Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)
• Multicenter Infection Surveillance Study Following Colorectal Procedures
• BAY 0 9867 Cipro Pediatric Use Study (QUIP)
• Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
• Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections
• Topical Gentamicin Cream Versus Alternating Gentamicin and Mupirocin Cream in Peritoneal Dialysis
• Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)
• Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy
• Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection
• Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection
• Does Treatment With Macrobid Reduce Urinary Tract Infections in Patients Receiving a Sub-Urethral Sling for Incontinence
• Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection
• Staphylococcus Aureus Decolonization Study
• Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients
• Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
• Bone Mineral Density Substudy - An Ancillary Study to MTN-003
• Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients
• The Role of Dendritic Cells in Hepatitis C Infection
• A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections
• Outcomes of Patients Who Fail to Respond to Fluconazole Treatment of Severe Candida Albicans Infections
• Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections
• Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART
• Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia
• A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)
• Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant
• Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar
• Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori
• Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection
• Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections
• Oseltamivir Randomised Controlled Efficacy Trial
• Effectiveness of Antiretroviral Therapy During Acute HIV Infection
• Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women
• Pharmacokinetic of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnancy
• Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis
• Vaginal Infection Study 2
• Wound Antiseptic Study With Hypochlorous Acid & Iodopovidone
• Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections
• Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED)
• Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)
• Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections
• Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)
• Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK580416
• Ethanol Locks for the Treatment of Central Venous Line Infections
• PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections
• Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management
• Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections
• Nitrofurantoin and Urinary Tract Infections (UTIs)
• Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections
• Multicenter Infection Surveillance Study Following Open Heart Surgery
• Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection
• BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis
• Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections
• Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract Infections
• Raltegravir as Early Therapy in African-Americans Living With HIV Study
• Sex, Aging and Antiretroviral Pharmacokinetics
• Antibiotic Therapy is Not Necessary to Implant Totally Implantable Venous Access Devices: Randomized Prospective Study
• Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance
• Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
• Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection
• Cubicin(R) for Complicated Post-surgical Wound Infections
• Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam
• Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
• Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China
• Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection
• Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge
• The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection
• Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa
• Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis
• Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
• Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons
• T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam
• Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study)
• Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of VCH 916 in Subjects With Chronic Hep C Infection
• Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections
• Complicated Skin and Skin Structure Infections
• MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection
• Orally Administered Trimethoprim-sulfamethoxazole and Metronidazole as Prophylaxis of Infection Following Elective Colorectal Surgery
• PRO 140 by IV Administration in Adults With HIV-1 Infection
• Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection
• A Study of an Antibiotic Implant in General Surgical Subjects at Higher Risk for Surgical Wound Infection
• Safety and Efficacy of an Antibiotic Implant in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Infection
• PulmonarOM (Bacterial Lysates) in Respiratory Tract Infections
• Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates
• Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
• Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women
• Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection
• Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery
• Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers
• Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection
• Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection
• Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers
• Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women
• A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection
• Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
• Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage
• Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.
• Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+
• Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children: a Randomised, Double-blind, Placebo-controlled Study
• Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)
• Study of Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit
• KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects
• Middle Meatal Bacteriology During Acute Respiratory Infection in Children
• Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
• Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-term Observational Study
• Role of Zinc in Recurrent Acute Lower Respiratory Infections
• Study of the Efficacy of Preoperative Cefuroxime Prophylaxis to Prevent Surgical Site Infection in Herniated Disk Surgery
• A Study of Ceftobiprole in Patients With Fever and Neutropenia.
• Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) Syndrome
• Treatment of Deficient Subclass or Anti-polysaccharide Antibody Response
• Integrase Inhibitor (MK-0518) Viral Decay
• Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections
• Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride
• A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia
• A Study for Patients With Complicated Skin and Skin Structure Infections
• The Natural History of Community-Associated MRSA Infections and Decolonization Strategies
• Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection
• Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression
• Safety Study of Oral BTA9881 to Treat RSV Infection
• An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia
• Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections
• Prophylaxis of Fungal Invasive Infections in Leukemia
• Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection
• Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem
• Antimicrobial PK in Infants With Suspected or Confirmed Infection
• Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI
• A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting
• Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age
• Local Collagen-Gentamicin and Extra Fixation of the Sternum for Prevention of Sternal Wound Infection in Cardiac Surgery
• First Time in Man Study of Finafloxacin Hydrochloride
• A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)
• Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas
• A Prospective Cohort of Children With HIV Infection
• Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection
• A PK and Salvage Study for Children With HIV-infection
• Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates
• Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura
• Catheter Related - Gram Positive Bloodstream Infections
• Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections
• LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
• Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections
• Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.
• Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
• Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection
• Voriconazole as Prophylactic Therapy in Lung Transplant Recipients
• Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)
• HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults
• Botswana TDF/FTC Oral HIV Prophylaxis Trial
• Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection
• Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection
• TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection
• Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV
• Pioglitazone to Treat Fatty Liver in People With HIV Infection
• Phase 4 Study - Mucinex D as Adjunct Therapy
• Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
• Pilot Study of the Utility of Empiric Antibiotic Therapy for Suspected ICU-Acquired Infection
• Assessment of Airway Obstruction in Infants With Lower Respiratory Infections
• A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.
• A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701
• Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections
• Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients
• Trimethoprim-Sulfamethoxazole or Doxycycline for Skin and Soft Tissue Infections
• A Three-Part Study Of GSK580416 In Healthy Subjects
• Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections
• Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections
• Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
• Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee Arthroplasty
• Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
• Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection
• Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections
• Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection
• A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection
• Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
• Japanese Study Evaluating Safety, Efficacy and Acceptability of Telithromycin in Children With Infections
• Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ACH-0137171 in Subjects With Chronic Hepatitis C Infection
• Use of Ointments in Prevention of Catheter Related Infections in PD
• Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection
• A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients
• Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults
• To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052)
• N-acetylcysteine in Intra-amniotic Infection/Inflammation
• Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection
• Aerosolized Antibiotics and Respiratory Tract Infection in Patients on Mechanical Ventilation
• Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients
• Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)
• Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection
• ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia
• A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects.
• A Study to Assess the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-048)
• Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection
• Study of Prophylactic Vs Preemptive Valganciclovir
• Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft Recipients
• Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection
• Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections
• Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.
• A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects
• A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections
• Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV
• Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption
• A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
• Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections
• Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
• Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 Infection
• Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose
• Therapeutic Zinc in Infant Bacterial Illness
• Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, Tanzania
• AUGMENTIN 1gm In Skin And Soft Tissue Infection
• Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic Filariasis
• Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection
• BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection
• Prophylaxis With Caspofungin in High-Risk Liver Transplantation
• Randomized Trial of Two Antimalarial Treatments for Clearing Low Density P.Falciparum Parasitaemia in Sudan
• Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
• Structured Treatment Interruptions in Chronic HIV Infection
• SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection
• The AOT (Acridine Orange and Taurolidine) Trial
• Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
• Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-inflammatory Effect of Chloroquine
• Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection
• Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients
• A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections
• Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)
• Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children
• Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli
• Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1)
• Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication
• Interaction Between HIV and Lymphatic Filariasis
• Efficacy Study of Antiseptic Preoperative Scrubs in Prevention of Postoperative Infections
• Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)
• An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers
• A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections
• Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh?
• Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis Patients
• Controlled Trial of Valacyclovir in Infectious Mononucleosis
• Lactulose for the Prevention of Nosocomial Infections in Children
• The Effects of Hypercapnia, Supplemental Oxygen, and Dexamethasone on Surgical Wound Infection
• Prevention of Nosocomial Infection by Decontamination of the Naso- and Oropharynx With Chlorhexidine (NONI Trial)
• Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia
• Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users
• Valganciclovir to Reduce T Cell Activation in HIV Infection
• Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
• Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections
• Telithromycin in Respiratory Tract Infections
• Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults
• Chlorhexidine vs Povidone Iodine in Alcoholic Solutions for Prevention of Central Venous Catheter Infection
• A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections
• A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections
• GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults
• A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Uncomplicated Infections of the Skin and the Supportive Layers Beneath the Skin
• A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin
• Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV
• Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.
• A Study of the Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Skin Infections
• Urinary Tract Infection Study With the Antibiotic Levofloxacin Given at a Higher Dose Over a Shorter Period of Time
• A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults
• Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)
• Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant
• Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection
• Catechin Gargling for Influenza Infection
• Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised
• Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems
• MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus
• A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections
• When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)
• QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection
• A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT
• Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters
• Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
• Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)
• Doripenem in the Treatment of Complicated Intra-Abdominal Infections
• Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis
• Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
• Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections
• Vitamin A and Zinc: Prevention of Pneumonia (VAZPOP) Study
• The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists
• Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients
• Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients
• Phase I/II, Open-Label Trial of Three Monoclonal Antibodies
• Observational Study of Treated and Untreated Acute and Early HIV-1 Infection
• Aurograb and Vancomycin in MRSA Infection
• Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.
• PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon
• HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy
• Once Daily 3TC, Efavirenz and ddI for HIV Infection
• Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF
• Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).
• Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis
• Doripenem in the Treatment of Complicated Intra-Abdominal Infections
• Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
• A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis.
• Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant
• Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections
• Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.
• Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection
• The Effect of H. Pylori Infection on Iron Metabolism
• Effect of Chlorhexidine Skin Cleansing on Skin Flora
• Etiology, Prevention and Treatment of Neonatal Infections in the Community
• Prevention of Milk-Borne Transmission of HIV-1C in Botswana
• Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
• HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection
• Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection
• Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection
• Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections.
• Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission
• Tenofovir in HIV/HBV Coinfection
• Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds
• Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants
• Placebo Controlled Study of Antibiotic Treatment of Soft Tissue Infection
• Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095
• Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus
• Reducing Vaginal Infections in Women
• Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)
• Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units
• Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care
• Breastfeeding, Antiretroviral, and Nutrition Study
• The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study
• The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships
• Topical Therapy for Prevention of Infections in Preterm Infants
• An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection
• An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada
• Oral vs Initial Intravenous Antibiotic Treatment of Urinary Tract Infections in Children: a RCT
• Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment
• A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)
• Evaluation of the Effectiveness of Antibiotic Prophylaxis in Children With a Previous Urinary Tract Infection
• Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections
• To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities
• Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.
• Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan
• Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
• Time To Efficacy and Onset Of Action Of Linezolid
• A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment
• Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options
• Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants
• Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of Birth Canal and Newborn
• Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
• Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections
• gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females
• Micronutrients and Enteric Infections in African Children
• KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections
• Influence of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda
• Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients
• Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation
• Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections
• Cranberry Juice for the Prevention of Recurrent Urinary Tract Infections
• Succinylated Human Serum Albumin (Suc-HSA) for HIV-1 Infection
• Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection
• Albumin Administration in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis
• Peripartum Bacteruria and Urinary Tract Infections (UTI)
• Cellulose Sulfate (CS) Gel and HIV in Nigeria
• Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)
• Antibiotic Efficacy in Third Molar Surgery
• Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
• VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.
• Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)
• Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants
• Staccato: A Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV Infection
• Study to Evaluate MEDI-534 in Healthy Adults
• Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection
• Botswana Tenofovir Oral HIV Prophylaxis Trial
• Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People
• "Prime-Boost" Vaccine Schedule for Prevention of HIV Infection
• Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections
• Preventing Staphylococcal (Staph) Infection
• Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus
• Anti-HIV Medications for People Recently Infected With HIV
• GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection
• GW873140 In Combination With Combivir In HIV Infected Subjects
• Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth
• Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections
• GW873140 In Combination With Kaletra In HIV Infected Subjects
• Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal
• RSV Challenge in Healthy Adults
• Effects of Cranberry-Containing Products in Women With Recurrent Urinary Tract Infections (UTIs)
• Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
• Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection
• Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)
• Fosamprenavir Versus Other Protease Inhibitors
• Cranberry Juice for Treatment of Urinary Tract Infections
• An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)
• Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus
• Hormonal Contraception and Risk of Chlamydia and Gonorrhea
• 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
• Identification of the Cranberry Juice Compounds That Prevent Urinary Tract Infections
• Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
• Three Month Course of Anti-HIV Medications for People Recently Infected With HIV
• KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
• Interactions Between Cranberry Juice and Antibiotics Used to Treat Urinary Tract Infections
• Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV
• Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV
• Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects
• Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia
• Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV
• Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms
• Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)
• A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons
• Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia
• Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
• A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes
• Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
• BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women
• A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation
• Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation
• Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
• Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
• Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections
• Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection
• Tuberculosis in HIV Infected Patients in Uganda
• Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria
• When to Start Anti-HIV Drugs in Patients With Opportunistic Infections
• Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients
• Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection
• CSP #512 - Options in Management With Anti-Retrovirals
• A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients
• Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
• Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection
• New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects
• Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection
• Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.
• A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection
• Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria
• New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)
• New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)
• PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)
• Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)
• Posaconazole to Treat Invasive Fungal Infections
• Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients
• Valganciclovir in Congenital CMV Infants
• Tenofovir Disoproxil Fumarate to Treat Pediatric HIV
• Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection
• TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz
• Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection
• A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections
• Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients
• Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
• Safety and Tolerability of Z-100 in Patients With Early HIV Infection
• Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation
• Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation
• Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection
• Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection
• Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
• Kidney Transplant for HIV-Infected Patients in Renal Failure
• Comparing Side Effects of Two Forms of Videx in HIV-Infected Adults
• A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)
• Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients
• Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection
• Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication
• Capravirine to Treat Children With HIV Infection
• Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection
• Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV
• Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns
• Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection
• A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection
• Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV
• Voriconazole to Prevent Systemic Fungal Infections in Children
• A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients
• Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma
• Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
• An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy
• Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs
• Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease
• Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting
• Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease
• Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women
• Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection
• Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections
• Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation
• Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
• Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection
• Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
• A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection
• A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs
• A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients
• A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
• The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients
• Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults
• A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir
• Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment
• The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
• A Study of Amprenavir in HIV-Infected Patients
• Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations
• A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients
• The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients
• A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients
• A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients
• The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients
• Study of Itraconazole in Patients With Advanced HIV Infection
• The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms
• A Study of Lobucavir in Patients With AIDS
• A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.
• The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection
• A Study of Azithromycin in HIV-Infected Patients
• A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS
• A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole
• A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX
• A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
• The Safety and Effectiveness of 935U83 in HIV-Infected Patients
• The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
• A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine
• The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS
• The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients
• A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
• The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis
• A Study of Nystatin in HIV-Infected Patients
• SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir
• A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients
• A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs
• A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients
• A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
• A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir
• The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
• The Safety and Effectiveness of Ribavirin in the Early Stages of HIV-Infection
• A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes
• The Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV Infection
• A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus
• A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS
• A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant
• A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS
• A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections
• A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS
• A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection
• A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria
• Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
• A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir
• A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection
• A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients
• A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors
• Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients
• A Study of a Combination of Four Drugs in Patients With Recent HIV Infection
• Phase I Trial of S-1153 in Patients With HIV Infection
• An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen
• A Study of 1592U89 in HIV-Infected Adults
• A Study of 1592U89 in HIV-Infected Children
• A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients
• Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.
• A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis
• Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)
• A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection
• The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection
• A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection
• A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection
• Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.
• A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)
• A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis
• Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study
• The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment
• A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients
• Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.
• A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.
• A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients
• A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection
• An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible fo
• A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection
• Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV
• A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo
• A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.
• A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine
• A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus
• A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection
• An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent
• An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)
• An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy
• A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection
• A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy
• A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
• Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study
• Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection
• Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis
• Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
• A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease
• Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients
• Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
• A Prospective Double-Blind Study of Retrovir in Early HIV Infection
• An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients
• Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study
• A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS
• Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
• Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient
• Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections
• A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia
• An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia
• A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia
• A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility
• A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients
• A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS
• Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients
• Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections
• Prevention of RSV Infections in Bone Marrow Transplant Recipients
• Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
• Combination Drug Treatment of Pediatric HIV Infection
• Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection
• An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
• Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections
• Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection
• Twins Study of Gene Therapy for HIV Infection
• Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up
• Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist
• A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection
• Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection
• Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)
• Interleukin-2 Therapy for HIV Infection - Supplemental Procedures
• Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma
• A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly
• Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV
• The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood
• The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV
• A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia
• A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.
• A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients
• The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients
• The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients
• A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole
• A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS
• The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients
• The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children
• A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV
• Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS
• Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
• A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients
• The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection
• The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections
• The Treatment of Tuberculosis in HIV-Infected Patients
• A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT
• The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients
• The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients
• Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS
• A Study of AL721 in HIV-Infected Patients With Swollen Lymph Nodes
• A Study of Zidovudine Plus Acyclovir in HIV-Infected Patients
• A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes
• A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time
• A Study of Zidovudine in HIV-Infected Patients With Liver Disease
• A Study of Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of Infection
• The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC
• A Study of Dideoxycytidine in HIV-Infected Patients
• A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection
• A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
• A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus
• A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS
• A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients
• Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir
• A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection
• A Study of Azidothymidine in HIV-Infected Children
• The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDS
• Comparison of ddI Versus Zidovudine in HIV-Infected Patients
• A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS
• A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia
• A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients
• The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS
• A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir
• A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS
• A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine
• The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients
• The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants
• Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection
• Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection
• A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3
• Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
• A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients
• Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
• A Study of Nonoxynol-9 (N-9) and HIV Infection
• The Effects of Prednisone on HIV Levels and the Immune System
• A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection
• A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children
• A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy
• Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children
• A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection
• A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
• Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy
• A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease
• Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection
• Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection
• A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
• The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children
• A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients
• A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.
• The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected Children
• A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months
• A Phase I Study of Methotrexate for HIV Infection
• Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites
• The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
• A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
• A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy
• A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection
• A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
• A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
• A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection
• Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection
• A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection
• Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)
• Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.
• A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection
• A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3
• Preventing Frequent Sinus Infections in HIV-Infected Patients
• A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
• Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection
• Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome
• A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
• A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection
• A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3
• Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms
• Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia
• A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection
• A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP
• A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis
• A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir
• A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure
• Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)
• A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy
• A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
• A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection
• A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir
• A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection
• Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component
• A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection
• The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU
• A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT
• A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection
• A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy
• An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)
• An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection
• A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS
• A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.
• Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
• Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
• Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine